RSV Vaccine Maintains Efficacy Across Two Seasons in Seniors

(MedPage Today) -- BOSTON -- Efficacy of GSK's respiratory syncytial virus (RSV) vaccine held strong through two RSV seasons in adults 60 and over, according to new results from the company's pivotal trial. With a single dose, efficacy of the...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news